The expansion of Tregs in CD4+ TILs might contribute to the immune evasion of SCCs via multiple mechanisms, because Tregs can inhibit CD8+ T cell-mediated tumor killing, directly kill antigen presenting cells or secrete a number of inhibitory factors which have immune suppressive effects [37]. The gene discussed is CD8A; the disease is neoplasm.